Evidence mapping of preference elicitation for non-pharmaceutical interventions targeting respiratory viral transmission: A scoping review protocol

INTRODUCTION: Non-pharmaceutical interventions (NPIs) such as mask use, physical distancing, business or school closure, and isolation have been central to controlling respiratory viral infections, including influenza, COVID-19, and respiratory syncytial virus (RSV). Understanding the preferences of the public and stakeholders for these interventions is critical to ensure their acceptability, uptake, and effectiveness. Discrete choice experiments (DCEs) provide a robust method to quantify how individuals value different attributes of NPIs and the trade-offs they are willing to make. However, evidence from DCEs is fragmented across diseases, populations, and methodological approaches. This scoping review aims to systematically map and synthesise evidence from DCEs examining public and stakeholder preferences for NPIs used in the prevention and control of influenza, COVID-19, and RSV. Specifically, it will: (1) summarise the attributes and attribute levels used in DCEs, and the methods employed to select them; and (2) identify which NPI attributes are most valued by the public and key stakeholders, including patients, healthcare workers, and policymakers. METHODS AND ANALYSIS: The review will follow the PRISMA-ScR framework. Comprehensive searches of electronic databases (PubMed, Scopus, and Embase) will identify DCEs evaluating NPIs for influenza, COVID-19, and RSV. Data extraction will capture study characteristics, target populations, attributes, experimental design, and analytical methods. Reporting quality will be appraised using the DIRECT Checklist. Given anticipated heterogeneity, findings will be synthesised narratively. By providing a structured overview of existing DCE evidence, this review will inform the design of future preference studies and guide the development of acceptable and evidence-based NPI strategies for respiratory viral infections. ETHICS AND DISSEMINATION: No ethical approval is required. The completed review will be shared through peer-reviewed journals and conference presentations. Open Science Framework Registration https://doi.org/10.17605/OSF.IO/H36UC.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-05-29
DOI
https://doi.org/10.1371/journal.pone.0344828
Primary Topic
Economic and Environmental Valuation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evidence mapping of preference elicitation for non-pharmaceutical interventions targeting respiratory viral transmission: A scoping review protocol

Samantha Marsh, Hui Yee Yeo, Lorraine Castelino, Nikki Turner et al.
PLoS ONE
Economic and Environmental Valuation
article

Evidence mapping of preference elicitation for non-pharmaceutical interventions targeting respiratory viral transmission: A scoping review protocol

Samantha Marsh, Hui Yee Yeo, Lorraine Castelino, Nikki Turner, Ji Yeon Park
article en

Abstract

INTRODUCTION: Non-pharmaceutical interventions (NPIs) such as mask use, physical distancing, business or school closure, and isolation have been central to controlling respiratory viral infections, including influenza, COVID-19, and respiratory syncytial virus (RSV). Understanding the preferences of the public and stakeholders for these interventions is critical to ensure their acceptability, uptake, and effectiveness. Discrete choice experiments (DCEs) provide a robust method to quantify how individuals value different attributes of NPIs and the trade-offs they are willing to make. However, evidence from DCEs is fragmented across diseases, populations, and methodological approaches. This scoping review aims to systematically map and synthesise evidence from DCEs examining public and stakeholder preferences for NPIs used in the prevention and control of influenza, COVID-19, and RSV. Specifically, it will: (1) summarise the attributes and attribute levels used in DCEs, and the methods employed to select them; and (2) identify which NPI attributes are most valued by the public and key stakeholders, including patients, healthcare workers, and policymakers. METHODS AND ANALYSIS: The review will follow the PRISMA-ScR framework. Comprehensive searches of electronic databases (PubMed, Scopus, and Embase) will identify DCEs evaluating NPIs for influenza, COVID-19, and RSV. Data extraction will capture study characteristics, target populations, attributes, experimental design, and analytical methods. Reporting quality will be appraised using the DIRECT Checklist. Given anticipated heterogeneity, findings will be synthesised narratively. By providing a structured overview of existing DCE evidence, this review will inform the design of future preference studies and guide the development of acceptable and evidence-based NPI strategies for respiratory viral infections. ETHICS AND DISSEMINATION: No ethical approval is required. The completed review will be shared through peer-reviewed journals and conference presentations. Open Science Framework Registration https://doi.org/10.17605/OSF.IO/H36UC.

PLoS ONEVol. 21(5)
University of Auckland (NZ)
Flu Lab
Openalex Percentile: Top 3%
Economic and Environmental Valuation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.